SSKN STRATA Skin Sciences, Inc.
Healthcare$0.15+0.00%ClosedMarket Cap: $697,531
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.30
P/S
0.02
EV/EBITDA
-16.05
DCF Value
$-1.07
FCF Yield
-611.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
57.8%
Operating Margin
-19.7%
Net Margin
-21.1%
ROE
-360.3%
ROA
-21.2%
ROIC
-31.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $9.3M | 60.4% | $37.0K | $58.0K | $— | — |
| FY null | $30.7M | 58.3% | $-5.8M | $-6.3M | $— | — |
| Q3 null | $6.9M | 60.4% | $-1.9M | $-1.6M | $— | — |
| Q2 null | $7.7M | 56.2% | $-2.2M | $-2.5M | $— | — |
| Q1 null | $6.8M | 53.5% | $-2.0M | $-2.4M | $— | — |
| Q4 null | $9.6M | 60.1% | $-4.2M | $-4.5M | $— | — |
| FY null | $33.6M | 56.9% | $-9.3M | $-10.1M | $— | — |
| Q3 null | $8.8M | 60.3% | $-1.7M | $-2.1M | $— | — |
| Q2 null | $8.4M | 58.5% | $-486.0K | $-99.0K | $— | — |
| Q1 null | $6.8M | 45.6% | $-2.9M | $-3.4M | $— | — |
| Q4 2023 | $8.7M | 55.3% | $-3.4M | $-3.8M | $-0.11 | — |
| FY null | $33.4M | 55.3% | $-8.6M | $-10.8M | $— | — |